Skip to main content
. Author manuscript; available in PMC: 2023 Sep 12.
Published in final edited form as: J Nat Prod. 2020 Dec 22;84(1):161–182. doi: 10.1021/acs.jnatprod.0c00968

Table 2.

Validated and potential drug targets and known NP inhibitors against Coronaviridae. Roman numbering corresponds to numbering in Figure1. Numbers in parenthesis corresponds to structures in Figures 510

Number Target Protein Function Natural Product Inhibitors NP-Inspired Inhibitors
Viral Proteins l Spike Glycoprotein Host cell recognition Griffithsin (2), Emodin (3) EK1 and other Spike fragments
II Main Protease (Mpro/3CLpro) Viral protein mauration Herbacetin (13), Rhoifolin (15), & other flavonoids Peptidomimetics
Tomentin A-E (16), Hirsutenone (17),
lll Papain-Like Protease (PLpro) Viral protein mauration Tanshinones (19), Psoralidin (18), and Inhibitors Needed
Others
IV RNA-dependent RNA polymerase (RdRp) Viral RNA replication Inhibitors Needed Favipiravir (22), Remdesivir (1), Ribavirin (23), Galidesivir (24), |3-D-N4-Hydroxycytidine (25)
V NSP1 Obstructs host cell protein synthesis and innate immune response Inhibitors Needed Inhibitors Needed
VI NSP13 Vrial helicase Myricetin (26), Scutellarein (27) Inhibitors Needed
VII Orf8b Obstructs innate immune response Inhibitors Needed Inhibitors Needed
Host Proteins VIII TMPRSS2 Cell membrane protease. Cleaves viral spike protein facilitating membrane fusion & entry Aprotinin (34) Inhibitors Needed
IX Cathepsin L Endosomal protease. Cleaves spike protein facilitating membrane fusion Gallinamide A (35), Nicolaidesin C (36), Grassypeptolide (37), E-64, Leupeptin (38) Other Reviews